Comment Letters
-
Mar 15, 2024
Senior Care Pharmacy Coalition Shares Comments with CMS Regarding Medicare Part D Restructuring Guidance: “Smoothing Provisions”
SCPC filed comments with CMS in response to their guidance on the implementation of the Medicare Part D restructuring portion of the Inflation Reduction Act (IRA).
-
Feb 26, 2024
Senior Care Pharmacy Coalition Urges Immediate Congressional Action to Protect Vulnerable Patients Following Cyberattack
SCPC members across the country have been affected by the recent UnitedHealth Group cyberattack. SCPC sent letters (linked below) to key leaders on Capitol Hill, asking them to step in and assist with delayed prescriptions to lessen the impact to LTC pharmacies.
-
Jan 20, 2023
Senior Care Pharmacy Coalition Provides Comments on Improving Care for Dually Eligible Enrollees
The Senior Care Pharmacy Coalition (SCPC), the only Washington-based organization exclusively representing the interests of long-term care (LTC) pharmacies, has responded to a Request for Information issued by a bipartisan group of Senators led by Senator Bill Cassidy (R-LA) regarding policy recommendations to improve care for enrollees dually eligible for Medicare and Medicaid programs (dual eligibles) and substantially reduce the amount of money both programs otherwise would expect to spend over time.
-
Jun 24, 2022
Senior Care Pharmacy Coalition Provides Comments on the Food and Drug Administration’s Proposed Opioid Mail-Back Notice
The Senior Care Pharmacy Coalition (SCPC) has submitted a comment letter to the Food and Drug Administration (FDA) regarding the agency’s notice of a policy to require that pharmacies include a “mail-back” envelope with every prescription dispensed in an outpatient setting. The notice, which is not a formal proposal to change existing policy, concerns a policy that would modify the current Opioid Analgesic Risk Evaluation and Mitigation Strategy.
-
Jun 8, 2022
Senior Care Pharmacy Coalition Applauds Federal Trade Commission Vote to Investigate Pharmacy Benefit Managers, Introduction of The Pharmacy Benefit Manager Transparency Act of 2022 by Senators Grassley and Cantwell
The Senior Care Pharmacy Coalition (SCPC), the only Washington-based organization exclusively representing the interests of long-term care (LTC) pharmacies applauds the Federal Trade Commission (FTC) for yesterday’s decision by to investigate Pharmacy Benefit Managers (PBMs) and the vertically integrated health care conglomerates which own them.
-
Mar 7, 2022
SCPC Provides Comments on CMS Proposed Rule Regarding Medicare Program
Dear Administrator Brooks-LaSure: The Senior Care Pharmacy Coalition (SCPC) appreciates the opportunity to comment on the CMS Proposed Rule entitled “Medicare Program: Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefits Programs;” Agency Docket Number CMS-4192-P (the Proposed Rule).1 SCPC is the only Washington-based organization exclusively representing the […]
-
Mar 4, 2022
SCPC provides comments on the Part D provisions of the 2023 CMS Call Letter
Dear Director Seshamani: The Senior Care Pharmacy Coalition (SCPC) appreciates the opportunity to comment on the Part D provisions of the 2023 CMS Call Letter entitled, “Advance Notice of Methodological Changes for Calendar Year (CY) 2023 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies” (the “Call Letter” or the […]
-
Sep 1, 2021
Long-Term Care Pharmacy CEOs Urge Sec. Becerra to Release Provider Relief Fund Dollars, Prioritize LTC Pharmacies
Washington, DC – Today, CEOs from long-term care (LTC) pharmacies across the nation – all members of the Senior Care Pharmacy Coalition (SCPC) – sent a letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra urging him to release the next distribution from the Provider Relief Fund immediately and to prioritize […]
-
Jul 23, 2021
SCPC’s Comment Letter on the Request for Information Regarding Reporting on Pharmacy Benefit and Prescription Drug Costs
SCPC urges the Administration to increase drug pricing transparency by collecting information from PBMs…
View Archives
By Date
- December 2024 (1)
- August 2024 (2)
- July 2024 (3)
- June 2024 (2)
- April 2024 (1)
- March 2024 (4)
- February 2024 (1)
- November 2023 (3)
- October 2023 (1)
- September 2023 (2)
- August 2023 (4)
- July 2023 (4)
- June 2023 (1)
- March 2023 (2)